PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.71%
G&A change of 30.71% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
-38.54%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
25.41%
Operating expenses growth exceeding 1.5x Healthcare median of 1.09%. Jim Chanos would check for waste.
25.41%
Total costs growth exceeding 1.5x Healthcare median of 2.17%. Jim Chanos would check for waste.
-10.64%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-25.41%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-25.41%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
353.66%
Other expenses change of 353.66% versus flat Healthcare. Walter Schloss would verify control.
100.00%
Income change of 100.00% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
-610.74%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
610.74%
Income change of 610.74% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
609.26%
EPS change of 609.26% versus flat Healthcare. Walter Schloss would verify quality.
609.26%
Diluted EPS change of 609.26% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.